Report Highlights
The report provides an overview of the global market for artificial blood vessels and its related segment. The report has been segmented based on type, application, and geographical region. Using 2022 as the base year, the report provides estimated market data for 2023 through 2028. The report also provides information on emerging technologies, ESG developments, and mergers and acquisitions, and strategic initiatives by various companies.
Report Includes
- An overview of the global market landscape related to the artificial blood vessels
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to artificial blood vessels, accompanied by a comprehensive market share analysis categorized by type, application, and geographical region
- Highlights of the current and future market potential and a detailed analysis of the regulatory framework and reimbursement scenarios
- Information on tissue-engineered vascular grafts (TEVGs), their clinical applications, and vascular grafts currently in use; and description of common materials used for artificial blood vessels such as synthetic polymers, natural biomaterials and hybrid materials
- Review of patents, product pipeline, ESG trends, and emerging technologies related to artificial blood vessels
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Report Scope
The scope of this study encompasses an investigation of the global market for artificial blood vessels, focusing on various important aspects of the market, demand for the product, the current and future market potential for artificial blood vessels and a detailed analysis of the competitive landscape.
BCC Research analyzes each market segment and provides a forecast for five years. The current report analyzes the market's drivers, challenges, and opportunities. The report also covers market projections through 2028 and the market share for key market players. The report includes the company profiles of key players with detailed information about their business segments, product portfolios, and recent developments. The report also provides information on emerging technologies, ESG developments, and mergers and acquisitions, and strategic initiatives by various companies.
Report Synopsis
| Report Metrics | Details | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||
| Forecast period considered | 2023-2028 | ||||||||
| Base year market size | $2.1 billion | ||||||||
| Market size forecast | $2.8 billion | ||||||||
| Growth rate | CAGR of 5.3% for the forecast period of 2023-2028 | ||||||||
| Units considered | $ Millions | ||||||||
| Segments covered | Type, Application | ||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||
| Key Market Drivers |
|
||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
- Increasing prevalence of cardiovascular diseases
- Increasing prevalence of peripheral artery disease and end-stage renal diseases
- Increasing geriatric population and changing lifestyle
- Increasing strategic initiatives
- The artificial blood vessels market is segmented based on type, application and region.
- Segmentation based on type includes expanded polytetrafluoroethylene (ePTFE), polyethylene terephthalate (like Dacron), or polyurethane and others.
- Segmentation based on application includes Aortic Disease, Peripheral Artery Disease and Hemodialysis. The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Artificial Organs: Global Markets
The global artificial organs market should reach $17.7 billion by 2028 from $14.4 billion in 2023 at a compound annual growth rate (CAGR) of 4.2% for the forecast period of 2023 to 2028.
Global Vascular Patches Market
The global vascular patches market reached $717.4 million in 2022 and should reach $1 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Artificial Vasculature and Micro-Environmental Factors Supporting Tissue Engineering and Organoids
This report presents an overview of the artificial vasculature and micro-environmental factors supporting tissue engineering and organoids. This report also evaluates current and emerging trends in artificial vasculature, recent breakthroughs, and major issues related to the use of these biocompatible vasculature systems.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More